Regulations financial management, cost-benefit

The principal role of the CRO is to contribute to the enhancement of the financial performance of its customers (Table 21.1). Improvement in the efficiency of their clients product development activities provides benefits to regulators, physicians and their patients. These include reduced cycle time, availability of external capacity, increased quality of trial management, and higher quality clinical data, all of which can result in lower labor costs. In late stage peri-approval trials, CROs may also play a role in developing safety profiles in large patient populations that are exposed to a new product after it is approved for manufacture and sale. Such trials can also assist the revenue growth of a new product. 

---